Celanese jumps 15% as investors refocus on deleveraging progress and improving outlook

Celanese Corporation (CE) is up 15.1% today. Here is some analysis on what might have caused this price movement.

Analysis: The move appears tied to a renewed “balance-sheet recovery” narrative: stronger-than-feared cash generation, a clearer path to debt reduction, and a more constructive view from at least one major sell-side firm on the chemical cycle. With no single company-specific headline dominating, the rally may also reflect investors repricing the stock after recent filings reiterated liquidity and deleveraging milestones.

Details:

A recent quarterly filing highlighted 2025 free cash flow of $773 million and outlined a 2026 free-cash-flow target of $650–$750 million alongside additional cost-savings goals.

The company described actions to manage near-term maturities, including refinancing activity that reduced 2026–2027 maturities versus prior levels, supporting the view that refinancing risk is easing.

A recent annual report stated the Micromax business sale closed on February 2, 2026 for $492 million (subject to customary adjustments), which can be used to pay down debt and support deleveraging.

This could also be because bullish analyst commentary recently turned more positive on demand normalization and operating leverage for chemical manufacturers, prompting short covering and multiple expansion in a heavily traded session.

Sources:

U.S. SEC, StockTitan, Investing.com

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$CE Insider Trading Activity

$CE insiders have traded $CE stock on the open market 2 times in the past 6 months. Of those trades, 2 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $CE stock by insiders over the last 6 months:

CHUCK KYRISH (SVP & CFO) purchased 5,000 shares for an estimated $205,150
SCOTT A RICHARDSON (CEO & President) purchased 3,800 shares for an estimated $158,041

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$CE Hedge Fund Activity

We have seen 204 institutional investors add shares of $CE stock to their portfolio, and 296 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

TURTLE CREEK ASSET MANAGEMENT INC. removed 2,958,825 shares (-57.8%) from their portfolio in Q4 2025, for an estimated $125,099,121
ROYAL BANK OF CANADA added 2,003,127 shares (+1539.8%) to their portfolio in Q4 2025, for an estimated $84,692,209
NORGES BANK removed 1,603,104 shares (-77.2%) from their portfolio in Q4 2025, for an estimated $67,779,237
ORBIS ALLAN GRAY LTD removed 1,304,050 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $55,135,234
CITADEL ADVISORS LLC added 1,079,063 shares (+92.2%) to their portfolio in Q4 2025, for an estimated $45,622,783
CAPITAL RESEARCH GLOBAL INVESTORS added 1,076,645 shares (+24.0%) to their portfolio in Q4 2025, for an estimated $45,520,550
POINT72 ASSET MANAGEMENT, L.P. added 1,052,380 shares (+508.6%) to their portfolio in Q4 2025, for an estimated $44,494,626

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$CE Analyst Ratings

Wall Street analysts have issued reports on $CE in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Citigroup issued a "Buy" rating on 12/18/2025
Wells Fargo issued a "Overweight" rating on 11/10/2025

To track analyst ratings and price targets for $CE, check out Quiver Quantitative's $CE forecast page.

$CE Price Targets

Multiple analysts have issued price targets for $CE recently. We have seen 8 analysts offer price targets for $CE in the last 6 months, with a median target of $55.5.

Here are some recent targets:

Patrick Cunningham from Citigroup set a target price of $81.0 on 03/12/2026
Arun Viswanathan from RBC Capital set a target price of $55.0 on 02/23/2026
Joshua Spector from UBS set a target price of $56.0 on 02/19/2026
Jeffrey Zekauskas from JP Morgan set a target price of $53.0 on 02/19/2026
Michael Sison from Wells Fargo set a target price of $55.0 on 02/19/2026
Stephen Richardson from Evercore ISI Group set a target price of $63.0 on 02/18/2026
Kieran De Brun from Mizuho set a target price of $55.0 on 02/18/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.